GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (OTCPK:EDTXF) » Definitions » Total Stockholders Equity

Spectral Medical (Spectral Medical) Total Stockholders Equity : $-12.34 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Spectral Medical Total Stockholders Equity?

Spectral Medical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-12.34 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Spectral Medical's Book Value per Share for the quarter that ended in Dec. 2023 was $-0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Spectral Medical's Debt-to-Equity for the quarter that ended in Dec. 2023 was -0.52.

Spectral Medical Total Stockholders Equity Historical Data

The historical data trend for Spectral Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical Total Stockholders Equity Chart

Spectral Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.72 -0.52 3.19 -1.88 -12.34

Spectral Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.88 -3.16 -5.48 -7.50 -12.34

Spectral Medical  (OTCPK:EDTXF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Spectral Medical's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-12.335-0)/278.576
=-0.04

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Spectral Medical's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.287 + 6.094) / -12.335
=-0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spectral Medical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Spectral Medical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Spectral Medical (Spectral Medical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (OTCPK:EDTXF) » Definitions » Total Stockholders Equity
Comparable Companies
XCNQ:SONA XCNQ:BUX TSXV:AVCR TSXV:TELO TSXV:ARC XCNQ:IZO TSXV:JUMP TSX:SZLS TSXV:MBI.H XCNQ:VTAL TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT
Traded in Other Exchanges
SD4:Germany EDT:Canada
Address
135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2
Website
https://www.spectraldx.com
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.